iRhythm Technologies (IRTC) Competitors $179.82 -1.21 (-0.67%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$177.00 -2.82 (-1.57%) As of 09/12/2025 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IRTC vs. ZBH, SNN, SOLV, PEN, STVN, BLCO, GKOS, TMDX, NVST, and LIVNShould you be buying iRhythm Technologies stock or one of its competitors? The main competitors of iRhythm Technologies include Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Bausch + Lomb (BLCO), Glaukos (GKOS), TransMedics Group (TMDX), Envista (NVST), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry. iRhythm Technologies vs. Its Competitors Zimmer Biomet Smith & Nephew SNATS Solventum Penumbra Stevanato Group Bausch + Lomb Glaukos TransMedics Group Envista LivaNova Zimmer Biomet (NYSE:ZBH) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings, valuation and dividends. Does the media prefer ZBH or IRTC? In the previous week, Zimmer Biomet had 4 more articles in the media than iRhythm Technologies. MarketBeat recorded 19 mentions for Zimmer Biomet and 15 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.54 beat Zimmer Biomet's score of 1.22 indicating that iRhythm Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zimmer Biomet 15 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive iRhythm Technologies 13 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do insiders and institutionals believe in ZBH or IRTC? 88.9% of Zimmer Biomet shares are owned by institutional investors. 0.7% of Zimmer Biomet shares are owned by company insiders. Comparatively, 0.7% of iRhythm Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more risk & volatility, ZBH or IRTC? Zimmer Biomet has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500. Do analysts prefer ZBH or IRTC? Zimmer Biomet presently has a consensus target price of $111.00, indicating a potential upside of 7.61%. iRhythm Technologies has a consensus target price of $163.82, indicating a potential downside of 8.90%. Given Zimmer Biomet's higher possible upside, equities analysts plainly believe Zimmer Biomet is more favorable than iRhythm Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zimmer Biomet 2 Sell rating(s) 7 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.39iRhythm Technologies 0 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.00 Is ZBH or IRTC more profitable? Zimmer Biomet has a net margin of 10.51% compared to iRhythm Technologies' net margin of -14.06%. Zimmer Biomet's return on equity of 12.76% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Zimmer Biomet10.51% 12.76% 7.21% iRhythm Technologies -14.06%-90.03%-8.52% Which has preferable valuation & earnings, ZBH or IRTC? Zimmer Biomet has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZimmer Biomet$7.68B2.66$903.70M$4.1125.10iRhythm Technologies$591.84M9.76-$113.29M-$2.93-61.37 SummaryZimmer Biomet beats iRhythm Technologies on 11 of the 17 factors compared between the two stocks. Get iRhythm Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRTC vs. The Competition Export to ExcelMetriciRhythm TechnologiesMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.78B$2.16B$5.78B$10.18BDividend YieldN/AN/A5.73%4.60%P/E Ratio-61.3738.0975.6326.02Price / Sales9.7610.28462.3591.38Price / CashN/A58.5825.8129.91Price / Book62.0111.6812.766.25Net Income-$113.29M-$63.67M$3.29B$270.76M7 Day Performance-3.88%-2.05%0.86%2.54%1 Month Performance11.98%2.88%4.70%5.73%1 Year Performance134.72%133.43%69.47%25.85% iRhythm Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRTCiRhythm Technologies1.2135 of 5 stars$179.82-0.7%$163.82-8.9%+134.7%$5.78B$591.84M-61.372,000Positive NewsZBHZimmer Biomet4.8085 of 5 stars$103.15-1.1%$111.00+7.6%-2.9%$20.43B$7.83B25.1017,000Positive NewsSNNSmith & Nephew SNATS3.1255 of 5 stars$37.77-2.0%$36.00-4.7%+19.9%$16.54B$5.81B17.4917,349SOLVSolventum2.103 of 5 stars$73.32-0.6%$85.11+16.1%+4.7%$12.71B$8.25B33.9522,000Positive NewsPENPenumbra4.5578 of 5 stars$273.54-1.0%$302.93+10.7%+46.3%$10.67B$1.28B72.754,500Positive NewsSTVNStevanato GroupN/A€26.43-1.6%N/A+37.2%€8.00B€1.19B48.955,521Gap UpBLCOBausch + Lomb2.0909 of 5 stars$15.22-0.7%$15.56+2.2%-2.2%$5.39B$4.79B-19.5113,500GKOSGlaukos4.7077 of 5 stars$82.74-5.4%$124.83+50.9%-34.5%$4.75B$432.95M-50.15780Positive NewsTMDXTransMedics Group2.541 of 5 stars$114.57-2.1%$122.11+6.6%-24.3%$3.91B$441.54M59.36210NVSTEnvista3.9066 of 5 stars$21.05-2.6%$20.92-0.6%+8.4%$3.50B$2.51B65.7712,300Positive NewsLIVNLivaNova2.9075 of 5 stars$56.22-2.0%$59.71+6.2%+15.8%$3.07B$1.25B-14.452,900Positive News Related Companies and Tools Related Companies Zimmer Biomet Alternatives Smith & Nephew SNATS Alternatives Solventum Alternatives Penumbra Alternatives Stevanato Group Alternatives Bausch + Lomb Alternatives Glaukos Alternatives TransMedics Group Alternatives Envista Alternatives LivaNova Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IRTC) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies Please log in to your account or sign up in order to add this asset to your watchlist. Share iRhythm Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
